sesamodil has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, S; Ichikawa, M; Koida, M; Machidera, Y; Manno, K; Nakamuta, H; Ohtsuji, T; Wanaka, M | 1 |
| Araki, S; Hashimoto, H; Ishii, M; Nagashima, S; Nakashima, M; Uematsu, T; Umemura, K | 1 |
| Chiba, K; Fukuzawa, A; Ishigai, Y; Mori, T; Shibano, T | 1 |
| Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nakaya, H; Tani, M; Uemura, H | 1 |
4 other study(ies) available for sesamodil and Disease Models, Animal
| Article | Year |
|---|---|
Antihypertensive effects of a novel calcium antagonist, semotiadil fumarate (SD-3211), alone and in combination with enalapril or trichlormethiazide in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; Heart Rate; Hypertension; Male; Rats; Rats, Inbred SHR; Thiazoles; Trichlormethiazide | 1994 |
Comparison of electrophysiologic and hemodynamic effects of SD-3212, a new antiarrhythmic drug, and flecainide in a canine myocardial infarction model.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Flecainide; Heart Conduction System; Hemodynamics; Myocardial Infarction; Thiazoles | 1994 |
Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
Topics: Acetylcholine; Angina Pectoris; Animals; Arginine Vasopressin; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Disease Models, Animal; Electrocardiography; Male; Nifedipine; Nisoldipine; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Thiazoles; Vasoconstrictor Agents | 1995 |
Electrophysiologic effects of SD-3212, a new class I antiarrhythmic drug, on canine atrial flutter and atrial action-potential characteristics.
Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Calcium Channel Blockers; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Heart Atria; Heart Conduction System; Sodium Channel Blockers; Thiazoles | 1997 |